ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.

Chelsea Bolyard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.